Skip to main navigation Skip to main content
  • KSPTM
  • E-Submission

PHD : Parasites, Hosts and Diseases

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

4
results for

"Amina Kariminia"

Article category

Keywords

Publication year

Authors

"Amina Kariminia"

Brief Communication

Purification and biochemical characterization of two novel antigens from Leishmania major promastigotes
Majid Zeinali, Sussan K. Ardestani, Amina Kariminia
Korean J Parasitol 2007;45(4):287-293.
Published online December 20, 2007
DOI: https://doi.org/10.3347/kjp.2007.45.4.287

The identification and characterization of antigens that elicit human T cell responses is an important step toward understanding of Leishmania major infection and ultimately in the development of a vaccine. Micropreparative SDS-PAGE followed by electrotransfer to a PVDF membrane and elution of proteins from the PVDF, was used to separate 2 novel proteins from L. major promastigotes, which can induce antibodies of the IgG2a isotype in mice and also are recognized by antisera of recovered human cutaneous leishmaniasis subjects. Fractionation of the crude extract of L. major revealed that all detectable proteins of interest were present within the soluble Leishmania antigens (SLA). Quantitation of these proteins showed that their expression in promastigotes is relatively very low. Considering the molecular weight, immunoreactivity, chromatographic and electrophoretic behavior in reducing and non-reducing conditions, these proteins are probably 2 isoforms of a single protein. A digest of these proteins was resolved on Tricine-SDS-PAGE and immunoreactive fragments were identified by human sera. Two immunoreactive fragments (36.4 and 34.8 kDa) were only generated by endoproteinase Glu-C treatment. These immunoreactive fragments or their parent molecules may be ideal candidates for incorporation in a cocktail vaccine against cutaneous leishmaniasis.

Citations

Citations to this article as recorded by  Crossref logo
  • Highly Effective Serodiagnosis for Chagas' Disease
    Pilar Hernández, Michael Heimann, Cristina Riera, Marco Solano, José Santalla, Alejandro O. Luquetti, Ewald Beck
    Clinical and Vaccine Immunology.2010; 17(10): 1598.     CrossRef
  • 7,354 View
  • 92 Download
  • Crossref
Original Articles
Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice
Ghassem Solgi, Amina Kariminia, Khossro Abdi, Majid Darabi, Behnaz Ghareghozloo
Korean J Parasitol 2006;44(1):55-61.
Published online March 20, 2006
DOI: https://doi.org/10.3347/kjp.2006.44.1.55

For treating Leishmania major infection in BALB/c mice, we used thalidomide in conjunction with glucantime. Groups of mice were challenged with 5 × 103 metacyclic promastigotes of L. major subcutaneously. A week after the challenge, drug treatment was started and continued for 12 days. Thalidomide was orally administrated 30 mg/kg/day and glucantime was administrated intraperitoneally (200 mg/kg/day). It was shown that the combined therapy is more effective than single therapies with each one of the drugs since the foot pad swelling in the group of mice received thalidomide and glucantime was significantly decreased (0.9 ± 0.2 mm) compared to mice treated with either glucantime, thalidomide, or carrier alone (1.2 ± 0.25, 1.4 ± 0.3, and 1.7 ± 0.27 mm, respectively). Cytokine study showed that the effect of thalidomide was not dependent on IL-12; however, it up-regulated IFN-γ and down-regulated IL-10 production. Conclusively, thalidomide seems promising as a conjunctive therapy with antimony in murine model of visceral leishmaniasis.

Citations

Citations to this article as recorded by  Crossref logo
  • Deciphering Molecular Mechanisms of Cutaneous Leishmaniasis, Pathogenesis and Drug Repurposing through Systems Biology
    Fatemeh Saberi, Zeinab Dehghan, Zahra Taheri, Tayyebeh Pilehchi, Hakimeh Zali
    Iranian Biomedical Journal.2024; 28(4): 179.     CrossRef
  • A standardized intraperitoneal Glucantime™ for experimental treatment of cutaneous leishmaniasis caused by Leishmania amazonensis in BALB/c mice
    Aline Ávila Brustolin, Nathália Martins Franzói, Áquila Carolina Fernandes Herculano Ramos-Milaré, Cínthia Akemi Tanoshi, Camila Alves Mota, Izabel Galhardo Demarchi, Maria Valdrinez Campana Lonardoni, Thaís Gomes Verzignassi Silveira
    Experimental Parasitology.2022; 236-237: 108259.     CrossRef
  • Effect of Synergism of Thalidomide and Liposomal Amphotericin-B on Leishmania tropica and Leishmania donovani Promastigote
    Nasma I. Al-Mamary, Haitham L. Al-Hayali
    Bionatura.2022; 7(2): 1.     CrossRef
  • Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice
    Alexandre C. Santana, Sabrina Degaspari, Sergio Catanozi, Humberto Dellê, Larissa de Sá Lima, Cleonice Silva, Paula Blanco, Kim Solez, Cristoforo Scavone, Irene L. Noronha
    Nephrology Dialysis Transplantation.2013; 28(5): 1140.     CrossRef
  • Immunomodulation by chemotherapeutic agents against Leishmaniasis
    Piu Saha, Debanjan Mukhopadhyay, Mitali Chatterjee
    International Immunopharmacology.2011; 11(11): 1668.     CrossRef
  • Immunomodulatory effect of picroliv on the efficacy of paromomycin and miltefosine in combination in experimental visceral leishmaniasis
    Shraddha A. Sane, Nishi Shakya, Suman Gupta
    Experimental Parasitology.2011; 127(2): 376.     CrossRef
  • Potential utility of hyperbaric oxygen therapy and propolis in enhancing the leishmanicidal activity of glucantime
    Diana Copi Ayres, Thiago Antonio Fedele, Maria Cristina Marcucci, Selma Giorgio
    Revista do Instituto de Medicina Tropical de São Paulo.2011; 53(6): 329.     CrossRef
  • Anni 2.0: a multipurpose text-mining tool for the life sciences
    Rob Jelier, Martijn J Schuemie, Antoine Veldhoven, Lambert CJ Dorssers, Guido Jenster, Jan A Kors
    Genome Biology.2008;[Epub]     CrossRef
  • 8,833 View
  • 94 Download
  • Crossref
Identification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice
Mohammad Reza Mohammadi, Majid Zeinali, Sussan K. Ardestani, Amina Kariminia
Korean J Parasitol 2006;44(1):43-48.
Published online March 20, 2006
DOI: https://doi.org/10.3347/kjp.2006.44.1.43

Experimental murine models with high, intermediate and low levels of genetically based susceptibility to Leishmania major infection reproduce almost entire spectrum of clinical manifestations of the human disease. There are increasing non-comparative studies on immune responses against isolated antigens of L. major in different murine strains. The aim of the present study was to find out whether there is an antigen that can induce protective immune response in resistant and susceptible murine strains. To do that, crude antigenic extract of procyclic and metacyclic promastigotes of L. major was prepared and subjected to SDS-PAGE electrophoresis. Western-blotting was used to search for antigen(s) capable of raising high antibody level of IgG2a versus IgG1 in the sera of both infected resistant and susceptible strains. Two novel antigens from metacyclic promastigotes of L. major (140 and 152 kDa) were potentially able to induce specific dominant IgG2a responses in BALB/c and C57BL/6 mice. The 2 antigens also reacted with IgG antibody of cutaneous leishmaniasis patients. We confirm that 140 and 152 kDa proteins of L. major promastigotes are inducing IgG production in mice and humans.

Citations

Citations to this article as recorded by  Crossref logo
  • Evaluation of Leishmania homolog of activated C kinase (LACK) of Leishmania donovani in comparison to glycoprotein 63 as a vaccine candidate against visceral leishmaniasis
    Nicky Didwania, Sudipta Bhowmick, Abdus Sabur, Anirban Bhattacharya, Nahid Ali, Monica R. Mugnier
    Microbiology Spectrum.2025;[Epub]     CrossRef
  • Diphencyprone reduces the CD8+ lymphocytes and IL-4 and enhences IgG2a/IgG1 ratio in pathogenicity of acute leishmania major infection in BALB/c mice
    Pourandokht Mousavian, Vahid Mashayekhi Goyonlo, Mohammad Javanbakht, Mahmoud Reza Jafari, Hamidreza Moosavian, Monovar Afzal Aghaei, Mohammadreza Malekzadeh
    Cytokine.2024; 184: 156792.     CrossRef
  • Immunological characterization of rLdTCP1γ for its prophylactic potential against visceral leishmaniasis in hamster model
    Apeksha Anand, Deep Chandra Balodi, Karthik Ramalingam, Shailendra Yadav, Neena Goyal
    Molecular Immunology.2022; 141: 33.     CrossRef
  • Adjuvanted vaccines driven protection against visceral infection in BALB/c mice by Leishmania donovani
    Deepak Kumar Goyal, Poonam Keshav, Sukhbir Kaur
    Microbial Pathogenesis.2021; 151: 104733.     CrossRef
  • Immune induction by adjuvanted Leishmania donovani vaccines against the visceral leishmaniasis in BALB/c mice
    Deepak Kumar Goyal, Poonam Keshav, Sukhbir Kaur
    Immunobiology.2021; 226(2): 152057.     CrossRef
  • Adjuvant effects of TLR agonist gardiquimod admixed with Leishmania vaccine in mice model of visceral leishmaniasis
    Deepak Kumar Goyal, Poonam Keshav, Sukhbir Kaur
    Infection, Genetics and Evolution.2021; 93: 104947.     CrossRef
  • The potential of live attenuated vaccines against Cutaneous Leishmaniasis
    A. Zabala-Peñafiel, D. Todd, H. Daneshvar, R. Burchmore
    Experimental Parasitology.2020; 210: 107849.     CrossRef
  • Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection
    Amir Ghasemi, Nazanin Mohammad, Josef Mautner, Mehrnaz Taghipour Karsabet, Jafar Amani, Abolfazl Ardjmand, Zarichehr Vakili
    Vaccine.2018; 36(34): 5124.     CrossRef
  • Evaluation of vaccinal effectiveness of preparations containing membrane antigens of Leishmania (L.) amazonensis in experimental cutaneous leishmaniasis model
    João G. Ribeiro, Amália S. Ferreira, Sharon R.A. Macedo, Norton R.D.L.P. Rossi, Mayara C.P. da Silva, Rosane N.M. Guerra, Neuza B. de Barros, Roberto Nicolete
    International Immunopharmacology.2017; 47: 227.     CrossRef
  • Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis
    Ankita Thakur, Harpreet Kaur, Sukhbir Kaur
    Parasitology International.2015; 64(1): 70.     CrossRef
  • Ox40L–Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major
    Rashmi Tuladhar, Steve Oghumu, Ran Dong, Allison Peterson, Arlene H. Sharpe, Abhay R. Satoskar
    Experimental Parasitology.2015; 148: 49.     CrossRef
  • Identification of immunodominant Leishmania major antigenic markers of the early C57BL/6 and BALB/c mice infection stages
    A. Sassi, O. Kaak, A. Ben Ammar Elgaied
    Parasite Immunology.2015; 37(10): 544.     CrossRef
  • Th1 Platform Immune Responses Against Leishmania major Induced by Thiol-Specific Antioxidant-Based DNA Vaccines
    Fatemeh Tabatabaie, Mehdi Mahdavi, Sobhan Faezi, Abdolhossein Dalimi, Zohreh Sharifi, Lame Akhlaghi, Fatemeh Ghaffarifar
    Jundishapur Journal of Microbiology.2014;[Epub]     CrossRef
  • Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB/c mice
    Jaspreet Kaur, Tejinder Kaur, Sukhbir Kaur
    Acta Tropica.2011; 119(1): 50.     CrossRef
  • Protective effect of lectin from Synadenium carinatum on Leishmania amazonensis infection in BALB/c mice
    Sandra R. Afonso-Cardoso, Flávio H. Rodrigues, Márcio A.B. Gomes, Adriano G. Silva, Ademir Rocha, Aparecida H.B. GuimarÃes, Ignês Candeloro, Sílvio Favoreto, Marcelo S. Ferreira, Maria A. de Souza
    The Korean Journal of Parasitology.2007; 45(4): 255.     CrossRef
  • Purification and biochemical characterization of two novel antigens from Leishmania major promastigotes
    Majid Zeinali, Sussan K. Ardestani, Amina Kariminia
    The Korean Journal of Parasitology.2007; 45(4): 287.     CrossRef
  • 7,739 View
  • 73 Download
  • Crossref
Production of nitric oxide by murine macrophages induced by lipophosphoglycan of Leishmania major
Gholamreza Kavoosi, Sussan K. Ardestani, Amina Kariminia, Zahra Tavakoli
Korean J Parasitol 2006;44(1):35-41.
Published online March 20, 2006
DOI: https://doi.org/10.3347/kjp.2006.44.1.35

Protozoan parasites of the genus Leishmania cause a number of important human diseases. One of the key determinants of parasite infectivity and survival is the surface glycoconjugate lipophosphoglycan (LPG). In addition, LPG is shown to be useful as a transmission blocking vaccine. Since culture supernatant of parasite promastigotes is a good source of LPG, we made attempts to characterize functions of the culture supernatant, and membrane LPG isolated from metacyclic promastigotes of Leishmania major. The purification scheme included anion-exchange chromatography, hydrophobic interaction chromatography and cold methanol precipitation. The purity of supernatant LPG (sLPG) and membrane LPG (mLPG) was determined by SDS-PAGE and thin layer chromatography. The effect of mLPG and sLPG on nitric oxide (NO) production by murine macrophages cell line (J774.1A) was studied. Both sLPG and mLPG induced NO production in a dose dependent manner but sLPG induced significantly higher amount of NO than mLPG. Our results show that sLPG is able to promote NO production by murine macrophages.

Citations

Citations to this article as recorded by  Crossref logo
  • Review on the Role of Host Immune Response in Protection and Immunopathogenesis during Cutaneous Leishmaniasis Infection
    Teshager Dubie, Yasin Mohammed, Patrice Xavier Petit
    Journal of Immunology Research.2020;[Epub]     CrossRef
  • Metformin partially reverses the inhibitory effect of co-culture with ER-/PR-/HER2+ breast cancer cells on biomarkers of monocyte antitumor activity
    Zoheir Dahmani, Lynda Addou-Klouche, Florence Gizard, Sara Dahou, Aida Messaoud, Nihel Chahinez Djebri, Mahmoud Idris Benaissti, Meriem Mostefaoui, Hadjer Terbeche, Wafa Nouari, Marwa Miliani, Gérard Lefranc, Anne Fernandez, Ned J. Lamb, Mourad Aribi, Sal
    PLOS ONE.2020; 15(10): e0240982.     CrossRef
  • Future Prospects in the Treatment of Parasitic Diseases: 2-Amino-1,3,4-Thiadiazoles in Leishmaniasis
    Georgeta Serban
    Molecules.2019; 24(8): 1557.     CrossRef
  • A new approach for development of vaccine against visceral leishmaniasis: Lipophosphoglycan and polyacrylic acid conjugates
    Adil M. Allahverdiyev, Rabia Cakir Koc, Melahat Bagirova, Serhat Elcicek, Serap Yesilkir Baydar, Olga Nehir Oztel, Emrah Sefik Abamor, Sezen Canim Ates, Murat Topuzogullari, Sevil Isoglu Dincer, Zeynep Akdeste
    Asian Pacific Journal of Tropical Medicine.2017; 10(9): 877.     CrossRef
  • Reactive Oxygen Species and Nitric Oxide in Cutaneous Leishmaniasis
    Maria Fátima Horta, Bárbara Pinheiro Mendes, Eric Henrique Roma, Fátima Soares Motta Noronha, Juan Pereira Macêdo, Luciana Souza Oliveira, Myrian Morato Duarte, Leda Quercia Vieira
    Journal of Parasitology Research.2012; 2012: 1.     CrossRef
  • DNA damage and nitric oxide production in mice following infection with L. chagasi
    Larissa Ragozo Cardoso de Oliveira, Gláucia Aparecida Gomes Cezário, Carlos Roberto Gonçalves de Lima, Vanessa Cristina Nicolete, Eliana Peresi, Maria Tereza de Síbio, Mariele Cristina Modolo Picka, Sueli Aparecida Calvi
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis.2011; 723(2): 177.     CrossRef
  • Antileishmanial Activity of 1,3,4-Thiadiazolium-2-Aminide in Mice Infected withLeishmania amazonensis
    Raquel F. Rodrigues, Karen S. Charret, Edson F. da Silva, Áurea Echevarria, Verônica F. Amaral, Leonor L. Leon, Marilene M. Canto-Cavalheiro
    Antimicrobial Agents and Chemotherapy.2009; 53(2): 839.     CrossRef
  • Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: An Iranian strain of cutaneous leishmaniasis
    Hossein Nahrevanian, Mahin Farahmand, Zohreh Aghighi, Mehdi Assmar, Aref Amirkhani
    Experimental Parasitology.2007; 116(3): 233.     CrossRef
  • 8,251 View
  • 86 Download
  • Crossref